Adam M Kase

12PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMedical virologyMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 27, 2025
Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing.

Miguel Muniz, L Jill Tsai, Jacob J Orme

|Jul 29, 2025
Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy.

Robert Seby, Benjamin J McCormick, Emily Wolf

|Mar 05, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer.

Adam M Kase, Justyna Gleba, James L Miller

|Feb 10, 2024
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.

Osama Mosalem, Winston Tan, Alan H Bryce

|Aug 12, 2023
The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.

Sanjeev Shukla, Carlos Riveros, Mohammed Al-Toubat

|Feb 22, 2023
Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review.

Adam M Kase, Abdel-Ghani Azzouqa, Swapna Kochuveettil

Pageof 2

Frequent Collaborators

3 joint publications

Ephraim E Parent

3 joint publications

Jacob Orme

2 joint publications

Hancheng Cai

1 joint publications

Muhamad Alhaj Moustafa